Search results
Results from the WOW.Com Content Network
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Out of 50 largest companies 23 are American, 17 Asian and 10 European. [2] This is limited to the largest 50 companies, all of which have annual revenues exceeding US$130 billion. This list is incomplete, as not all companies disclose their information to the media or general public. [3]
[2] [3] It is the nation's largest privately held manufacturer and distributor of medical supplies providing products, education, clinical programs and services across the continuum of care with operations in over 125 countries and territories. [4] In 2022, Medline had sales of $21.2 billion. [5]
Almost $23 billion and counting. To give some idea of the sheer size of Johnson & Johnson, a glance at its reported sales figure is revealing. In the fourth quarter alone, it earned more than $22. ...
Boston, which generates most of its revenue from sales of heart devices such as pacemakers and stents, will pay $27.50 for each share of Silk Road held, representing a premium of 27% to the stock ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Philips said it had agreed to pay $1.1 billion to settle all personal injury claims filed in the U.S., ending uncertainty that had slashed its market value over the past three years.
We do not know how much money device manufacturers pay to physicians. However, the Government’s recent investigations of several manufacturers of hip and knee surgical implants offer some insight. In 2005, the orthopedic device market for hips and knees witnessed domestic sales in excess of $5.1 billion and worldwide sales of more than $9.4